BioCentury | Sep 24, 2012
Company News

Biota, Nabi deal

...30 from Oct. 31 (see BioCentury, April 30). Nabi and Biota also said Nabi investor Mangrove Partners...
BioCentury | Aug 27, 2012
Clinical News

Inavir laninamivir: Phase III data

...a U.S.-headquartered company with a NASDAQ listing (see BioCentury, April 30). Earlier this month, Investor Mangrove Partners...
BioCentury | Aug 20, 2012
Company News

Nabi infectious, neurology news

...Investor Mangrove Partners Fund L.P. sent a letter to Nabi shareholders recommending that shareholders vote against the...
BioCentury | Dec 12, 2011
Company News

Celsion drug delivery, cancer news

...Investor Mangrove Partners Fund L.P. sent a letter to Celsion's board requesting several actions including the immediate...
BioCentury | Mar 21, 2011
Finance

Highlights of weekly biotech stock moves

...delivery company CPEX Pharmaceuticals Inc. (NASDAQ:CPEX) was up $0.41 to $27.55 last week after investor Mangrove Partners...
BioCentury | Mar 21, 2011
Company News

CPEX drug delivery news

...Investor Mangrove Partners Fund L.P. sent an unsolicited, non-binding letter to CPEX's board proposing a recapitalization implemented...
BioCentury | Mar 14, 2011
Company News

CPEX, Footstar Inc. drug delivery, endocrine news

...2, CPEX sent a letter to shareholders disputing claims in a previous statement from investor Mangrove Partners...
BioCentury | Mar 7, 2011
Company News

CPEX, Footstar deal

...Investor Mangrove Partners Fund L.P. said it would vote against the sale of CPEX to holding company...
Items per page:
1 - 8 of 8
BioCentury | Sep 24, 2012
Company News

Biota, Nabi deal

...30 from Oct. 31 (see BioCentury, April 30). Nabi and Biota also said Nabi investor Mangrove Partners...
BioCentury | Aug 27, 2012
Clinical News

Inavir laninamivir: Phase III data

...a U.S.-headquartered company with a NASDAQ listing (see BioCentury, April 30). Earlier this month, Investor Mangrove Partners...
BioCentury | Aug 20, 2012
Company News

Nabi infectious, neurology news

...Investor Mangrove Partners Fund L.P. sent a letter to Nabi shareholders recommending that shareholders vote against the...
BioCentury | Dec 12, 2011
Company News

Celsion drug delivery, cancer news

...Investor Mangrove Partners Fund L.P. sent a letter to Celsion's board requesting several actions including the immediate...
BioCentury | Mar 21, 2011
Finance

Highlights of weekly biotech stock moves

...delivery company CPEX Pharmaceuticals Inc. (NASDAQ:CPEX) was up $0.41 to $27.55 last week after investor Mangrove Partners...
BioCentury | Mar 21, 2011
Company News

CPEX drug delivery news

...Investor Mangrove Partners Fund L.P. sent an unsolicited, non-binding letter to CPEX's board proposing a recapitalization implemented...
BioCentury | Mar 14, 2011
Company News

CPEX, Footstar Inc. drug delivery, endocrine news

...2, CPEX sent a letter to shareholders disputing claims in a previous statement from investor Mangrove Partners...
BioCentury | Mar 7, 2011
Company News

CPEX, Footstar deal

...Investor Mangrove Partners Fund L.P. said it would vote against the sale of CPEX to holding company...
Items per page:
1 - 8 of 8